Results 11 to 20 of about 186,179 (282)

Revving up natural killer cells and cytokine-induced killer cells against hematological malignancies [PDF]

open access: yesFrontiers in Immunology, 2015
Natural killer (NK) cells belong to innate immunity and exhibit cytolytic activity against infectious pathogens and tumor cells. NK-cell function is finely tuned by receptors that transduce inhibitory or activating signals, such as killer immunoglobulin ...
Gianfranco ePittari   +4 more
doaj   +4 more sources

Biological Character of RetroNectin Activated Cytokine-Induced Killer Cells [PDF]

open access: yesJournal of Immunology Research, 2016
Adoptive cell therapy (ACT) using autologous cytokine-induced killer (CIK) cells is a promising treatment for metastatic carcinomas. In this study, we investigated the impact of RetroNectin on the proliferation, phenotype alternation, cytokine secretion,
Lu Han   +3 more
doaj   +3 more sources

Cytokine-induced killer cells are type II natural killer T cells

open access: yesGMS German Medical Science, 2007
Background: Until now, cytokine-induced killer (CIK) cells were assumed to be part of the type I natural killer T (NKT) cell population, but it was not yet investigated if this is correct.
Schmidt-Wolf, Ingo G.H.   +3 more
doaj   +3 more sources

Efficient killing of radioresistant breast cancer cells by cytokine-induced killer cells [PDF]

open access: yesTumor Biology, 2017
Recurrence of breast cancer after radiotherapy may be partly explained by the presence of radioresistant cells. Thus, it would be desirable to develop an effective therapy against radioresistant cells. In this study, we demonstrated the intense antitumor
Qingming Guo   +8 more
doaj   +3 more sources

Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy [PDF]

open access: yesFrontiers in Immunology, 2017
Cytokine-induced killer (CIK) cells are a heterogeneous population of effector CD3+CD56+ natural killer T cells, which can be easily expanded in vitro from peripheral blood mononuclear cells.
Xingchun Gao   +11 more
doaj   +3 more sources

Cytokine-induced killer cells: A novel treatment for allergic airway inflammation. [PDF]

open access: yesPLoS ONE, 2017
The effectiveness of cytokine-induced killer (CIK) cells for treatment of cancers has long been appreciated. Here, we report for the first time that CIK cells can be applied to treat allergic airway inflammation.
Panwadee Pluangnooch   +3 more
doaj   +5 more sources

Cytokine Induced Killer Cells as Promising Immunotherapy for Solid Tumors [PDF]

open access: yesJournal of Cancer, 2011
Cytokine-induced killer (CIK) cells are a heterogeneous subset of ex-vivo expanded T lymphocytes which present a mixed T-NK phenotype and are endowed with a MHC-unrestricted antitumor activity. The main functional properties of CIK cells may address some
Dario Sangiolo
doaj   +4 more sources

Effect of chaetocin on renal cell carcinoma cells and cytokine-induced killer cells [PDF]

open access: yesGMS German Medical Science, 2016
We examined the cytotoxic effects of chaetocin on clear cell renal cell carcinoma (ccRCC) cells and the possibility to combine the effects of chaetocin with the effects of cytokine-induced killer cells (CIK) assayed by MTT assay and FACS analysis ...
Rombo, Roman   +2 more
doaj   +3 more sources

Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer: A meta-analysis. [PDF]

open access: yesMedicine (Baltimore), 2021
Abstract Objectives: This meta-analysis was designed to systematically evaluate whether autologous cytokine-induced killer cells (CIK) or dendritic cells and cytokine-induced killer cells (DC-CIK) immunotherapy combined with chemotherapy can improve the therapeutic effect and safety of chemotherapy in esophageal ...
Yuan X   +11 more
europepmc   +4 more sources

Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer [PDF]

open access: yesBMC Cancer, 2020
AbstractBackgroundThis study aimed to investigate the efficacy and safety of cytokine-induced killer (CIK)/dendritic cell combined with CIK (DC–CIK) cell therapy in advanced gastrointestinal cancer (GIC).MethodsThe PubMed, Cochrane library, and Embase were searched to conduct a meta-analysis of clinical controlled trials to evaluate the efficacy and ...
Hansong Du, Jia Yang, Ying Zhang
openaire   +3 more sources

Home - About - Disclaimer - Privacy